Polly A. Murphy

Polly is an experienced pharmaceutical executive with extensive business development, commercial, and operations experience.

Polly joined UroGen following 12 years at Pfizer where she most recently served as the Vice President for Early Commercial Development in the Oncology Business Unit. Previously, she had senior leadership roles in both the Worldwide Business Development team and in Pfizer China Operations, spending over three years living and working in Beijing. Before joining Pfizer, Polly worked at The Scripps Research Institute as the Senior Vice President, Business and Scientific Services where she oversaw licensing and scientific operations. Polly is currently a member of the Board of Directors at Atea Pharma.

Polly received her Doctor of Veterinary Medicine and Ph.D. in Veterinary Pathology from Iowa State University, as well as a Master of Business Administration from Nova Southeastern University.